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Toll-Like Receptor 2–Deficient Mice Are Highly Susceptible to Streptococcus
pneumoniae Meningitis because of Reduced Bacterial Clearing and Enhanced
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Toll-like receptor–2 (TLR2) mediates host responses to gram-positive bacterial wall com-
ponents. TLR2 function was investigated in a murine Streptococcus pneumoniae meningitis
model in wild-type (wt) and TLR2-deficient (TLR2/) mice. TLR2/ mice showed earlier
time of death than wt mice ( ). Plasma interleukin-6 levels and bacterial numbers inP ! .02
blood and peripheral organs were similar for both strains. With ceftriaxone therapy, none of
the wt but 27% of the TLR2/ mice died ( ). Beyond 3 hours after infection, TLR2/P ! .04
mice had higher bacterial loads in brain than did wt mice, as assessed with luciferase-tagged
S. pneumoniae by means of a Xenogen-CCD (charge-coupled device) camera. After 24 h,
tumor necrosis factor activity was higher in cerebrospinal fluid of TLR2/ than wt mice
( ) and was related to increased blood-brain barrier permeability (Evans blue staining,P ! .05
). In conclusion, the lack of TLR2 was associated with earlier death from meningitis,P ! .02
which was not due to sepsis but to reduced brain bacterial clearing, followed by increased
intrathecal inflammation.
Streptococcus pneumoniae is the major cause of meningitis in
adults. Despite antimicrobial therapy and critical care medicine,
the mortality remains as high as 28% [1]. In addition, 50% of
the survivors have neurologic sequelae, indicating postinflam-
matory damage [2]. In the pathogenesis of meningitis, pene-
tration of bacteria through the blood-brain barrier (BBB) in-
itiates activation of brain endothelia and leads to leukocyte
recruitment and release of inflammatory mediators. Subse-
quently, the subarachnoidal inflammation stimulates astrocytes,
microglia, and neurons to produce cytokines and chemokines
[3–5]. A bacterial level of 5 log cfu in the brain initiates a
harmful inflammatory cascade, which causes development of
symptoms and determines the prognosis [6].
Pneumococci enter into the cerebral compartment through
the BBB via binding of their cell-wall component phosphoryl-
choline to the platelet-activating factor receptors expressed on
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activated cells [7, 8]. In view of the finding that antagonists of
the platelet-activating factor receptor do not completely block
bacterial invasion [7, 8], other cell-wall components, such as
peptidoglycan and lipoteichoic acid, might also induce inflam-
mation via activation of pattern recognition receptors expressed
in these cells [9].
Toll was first cloned in Drosophila species [10] and was found
to be involved in host defense against fungal infection [11]. In
humans, 10 homologous genes have been identified encoding
Toll-like receptors (TLRs) [12–14]. TLR2 is involved in cell
activation by gram-positive bacterial cell wall and membrane
components, such as peptidoglycan, lipoteichoic acid, and li-
poproteins [15–17]. Accordingly, macrophages isolated from
TLR2-deficient (TLR2/) mice are hyporesponsive to Staph-
ylococcus aureus peptidoglycan stimulation [18]. Despite grow-
ing evidence implicating TLR2 in recognition of gram-positive
bacterial cell-wall components in vitro, its role in bacterial men-
ingitis is still unknown. In this study, we compared disease
severity and outcome in TLR2/ and wild-type (wt) mice in
an adult mouse model of S. pneumoniae and Listeria monocyto-
genes meningitis. Bacterial numbers in the brain, bacterial
counts, and leukocyte recruitment into the subarachnoid space,
as well as meningeal inflammation and BBB permeability, were
analyzed.
Materials and Methods
Preparation of bacterial inocula. S. pneumoniae (clinical isolate
of serotype 3) was grown for 7 h in double Mueller-Hinton broth
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Figure 1. A, Percentage of wild-type (wt; ) and Toll-like re-np 22
ceptor-2–deficient (TLR2/; ) mice showing high severity scorenp 21
(including score 4 and score 5) after intracerebral injection of 2  102
cfu of Streptococcus pneumoniae. Data from 3 independent experiments
are represented as the mean percentage of high severity score  SD.
** , repeated-measures analysis of variance (ANOVA). B, Sur-P ! .02
vival of TLR2/ ( ) and wt ( ) mice after intracerebralnp 21 np 22
injection of cfu of S. pneumoniae. , log-rank test.22 10 P ! .02
(Difco Laboratories), subcultured overnight in new Mueller-Hin-
ton broth, and washed in 0.9% sterile saline (12,000 g for 6 min)
immediately before use. The inoculum size was calculated from
optical density determinations (optical density of 80.4p 1 10
cfu) and was retrospectively assessed by counting colony-forming
units on blood agar plates. L. monocytogenes (strain EGD; pro-
vided by R. M. Zinkernagel, University Hospital, Zu¨rich) was
grown overnight at 37C, yielding cfu in trypticase soy91–2 10
broth (BBL Microbiology Systems).
Mouse meningitis models. Six- to eight-week-old C57BL/6 wt
(RCC) and TLR2/ mice (provided by William J. Rieflin, Tularik,
South San Francisco, CA; mice had been back-crossed for 6 gen-
erations on a C57BL/6 background) were kept under specific path-
ogen–free conditions. Mice were anesthetized via intraperitoneal
injection of 100 mg/kg ketamine (Ketalar; Warner-Lambert) and
20 mg/kg xylazinum (Xylapan; Graeub) and subsequently inocu-
lated intracerebrally into the left forebrain with either 0.9% NaCl,
live S. pneumoniae ( or cfu), or live L. monocytoge-2 32 10 3 10
nes ( cfu) in a 25-mL volume. In addition to the intracerebral25 10
inoculation, selected experiments were done by an intracisternal
route of infection, as described elsewhere for experimental men-
ingitis in infant rats [19]. Mice ( each C57BL/6 wt andnp 10
TLR2/) were deeply anesthetized and infected by direct intracis-
ternal injection of 10 mL of saline containing 8.5 log10 cfu/mL S.
pneumoniae by means of a 32-gauge needle.
The health status of the mice was assessed by the following
scores, as described elsewhere [20]: 1, exhibited normal motor ac-
tivity and turned upright in !5 s when put on its back; 2, showed
decreased spontaneous activity, but still turned upright in !5 s; 3,
turned upright in 15 s; 4, did not turn upright; or 5, did not move.
After 6, 12, 24, 48, and 72 h or if they presented with a score of
5, mice were killed by intraperitoneal injection of 100 mg/kg pen-
tobarbital (Abbott Laboratories). Blood was obtained by intra-
cardiac puncture and collected in EDTA. Animals were perfused
with Ringer’s solution (Braun Medical) into the left cardiac ven-
tricle until the effluent became clear. Cerebrospinal fluid (CSF) was
obtained by puncture of the cisterna magna, as described elsewhere
[21]. Because of the small volumes (3–6 mL) obtained from each
animal, CSF from 4 mice was pooled.
Selected mice were treated with 80 mg/kg ceftriaxone (Rocephin;
Hoffmann–La Roche) dissolved in 0.1 mL of saline via intraper-
itoneal injection twice daily for 5 days. Treatment was started 18
h after infection. For the leukocyte depletion treatment, cyclo-
phosphamide (Sigma) was reconstituted with sterile PBS and in-
jected intraperitoneally (250 mg/kg in 0.2 mL) 48 h before S. pneu-
moniae inoculation.
Real-time in vivo imaging study of meningitis with use of biolumines-
cent S. pneumoniae transformed with gram-positive lux transposon.
Mice were intracerebrally injected with cfu of luciferase-tagged33 10
S. pneumoniae serotype 3 (Xen10) and subsequently shaved for better
imaging. This bacterial strain (provided by L. Chen; Xenogen) was
constructed as described elsewhere [22]. After infection, analysis of
photons was done repeatedly in mice under isoflurane inhalation an-
esthesia in an IVIS CCD (charge-coupled device) camera (Xenogen)
coupled to the LivingImage software package (Xenogen).
Determination of bacterial counts and inflammatory parameters.
Blood samples collected in EDTA and pooled CSF samples were
serially diluted in 0.9% NaCl to assess the bacterial load after
plating and incubation at 37C for 24 h. Blood and CSF were
centrifuged at 10,000 g for 20 min (4C), and CSF was centrifuged
at 800 g for 7 min (room temperature), to obtain plasma and cell-
free CSF, respectively. Thereafter, they were stored at 20C until
cytokine determinations were done. The pelleted CSF cells were
counted and identified via cytospin or were phenotypically ana-
lyzed. Brains were removed, and hemispheres were separated and
homogenized with a Polytron homogenizer in 1 mL of 0.1 mol/L
PBS. Bacterial titers were determined by plating serial 10-fold di-
lutions in 0.9% NaCl on blood agar plates. The concentration of
the proinflammatory cytokine tumor necrosis factor (TNF) in
plasma and CSF was determined with a bioassay, measuring the
degree of cytotoxicity on WEHI cells in the presence of 1 mg/mL
actinomycin D, with use of mouse recombinant TNF as a standard.
Interleukin (IL)–6 in plasma was measured by a mouse IL-6 ELISA
kit (OptEIA; PharMingen).
Evaluation of BBB integrity. BBB permeability was assessed
by measuring Evans blue extravasation, according to a method
described elsewhere [23]. Evans blue (0.2 mL, 2% in NaCl; Sigma)
was injected into the tail vein of infected (24 or 48 h) mice 60 min
before death. Mice were perfused as described above, their brains
were removed, and the hemispheres were separated. Each hemi-
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Table 1. Mean survival time of Listeria meningitis
in Toll-like receptor-2–deficient (TLR2/) and wild-
type (wt) mice.
Mouse strain
No. of
mice
Survival time,
mean h  SD P
wt 11 91.5  20.4 !.02a
TLR2/ 19 71.5  16.5 —
NOTE. Female mice (6–8-weeks old) were infected in-
tracerebrally with cfu of L. monocytogenes in 25 mL25 10
of NaCl.
a Log-rank test in Kaplan-Meier analysis.
Figure 2. Colony-forming unit counts in blood (A) and interleukin
(IL)–6 levels in plasma (B) in wild-type (wt; ) and Toll-likenp 22
receptor-2–deficient (TLR2/; ) mice after intracerebral injec-np 21
tion of cfu of Streptococcus pneumoniae. Blood was collected33 10
24, 48, and 72 h after infection. Results from individual mice are shown.
Horizontal line, mean. , Mann-Whitney U test.P 1 .05
sphere was homogenized in 1 mL of 0.1 mol/L PBS and then cen-
trifuged at 1000 g for 15 min; 0.7 mL of 100% trichloroacetic acid
was added to 0.7 mL of the supernatant. The mixture was incubated
at 4C for 18 h and then centrifuged at 1000 g for 30 min. The
amount of Evans blue in the supernatant was measured spectro-
photometrically at 610 nm and compared with a serially diluted
standard solution. Results were expressed as micrograms per brain
hemisphere.
Statistical analysis. Differences in survival between wt and
TLR2/ mice were tested by the Kaplan-Meier analysis log-rank
test. Data of disease severity scores were assessed by analysis of
variance corrected for repeated measurements, followed by posthoc
analysis (Fisher’s P least-squares difference, Scheffe, and Bonfer-
roni/Dunn tests). Results of the colony-forming unit measurements
and IL-6 levels in blood were compared by the Mann-Whitney U
test. Differences in CSF parameters between wt and TLR2/ mice
were analyzed with the nonparametric Wilcoxon signed rank test.
The relationship between 2 parameters (parametric variables) was
assessed in a linear regression model with the Spearman rank cor-
relation test. In all statistical tests, 5 was considered to beP ! .0
statistically significant.
Results
TLR2/ mice have a higher susceptibility to S. pneumoniae
and L. monocytogenes meningitis. To evaluate the in vivo
role of TLR2 during gram-positive bacterial meningitis, wt and
TLR2/ mice were infected intracerebrally with S. pneumoniae
or L. monocytogenes. The severity of the disease was monitored
by assessing both the clinical score and the survival rate.
Control animals, injected with 0.9% NaCl, showed no altered
health status. Infected mice remained free of clinical signs of
meningitis at 6 and 12 h after infection but had gradually re-
duced spontaneous activity between 12 and 24 h (data not
shown). As shown in figure 1A, both wt and TLR2/ mice
became severely sick during S. pneumoniae meningitis. The per-
centage of severely ill mice was significantly higher among
TLR2/ than control mice after 72 h ( , repeated-mea-P ! .02
sures analysis of variance). Indeed, only 30% of TLR2/ mice
survived at 72 h, and all died at 102 h after infection (figure
1B), whereas 60% of the wt mice survived at 72 h and died
of S. pneumoniae meningitis later (136 h after infection).
TLR2/ mice also showed reduced survival time ( , Kap-P ! .02
lan-Meier analysis), compared with wt mice with L. monocyto-
genes meningitis (table 1). These results show that TLR2/
mice had more severe symptoms and earlier death than did wt
mice during S. pneumoniae and L. monocytogenes meningitis.
Higher disease severity in TLR2/ mice is independent of sep-
sis. To investigate whether the high susceptibility of TLR2/
mice to meningitis was due to impaired host defense, colony-
forming units in blood were counted 1, 2, and 3 days after in-
fection with cfu of S. pneumoniae. Bacterial counts were33 10
similar in wt and TLR2/ mice at all time points (figure 2A).
Six and 12 h after infection, !10% of both wt and TLR2/ mice
showed positive blood culture results at low bacterial density
(data not shown).
Plasma IL-6, a prognostic marker of sepsis [24], was also
analyzed during meningitis. In accordance with bacterial
counts, IL-6 levels were not significantly different in wt and
TLR2/ mice 1–3 days after infection (figure 2B). Twelve and
24 h after intracerebral infection, emitted photons from lucif-
erase-tagged S. pneumoniae were analyzed in peripheral organs
(figure 3). Twenty-four hours after infection, fluorescence ac-
cumulated only in the lung with a similar intensity in wt and
TLR2/ mice. No other organ showed a detectable level of
emitted photons 12 and 24 h after infection. Taken together,
these data indicate that wt and TLR2/ mice had a similar
severity of sepsis and therefore an intact systemic host defense
during S. pneumoniae meningitis.
To differentiate between sepsis and inflammation as a cause
of death, wt and TLR2/ mice received antibiotic treatment
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Figure 3. Emitted photons by luciferase-tagged Streptococcus pneumoniae in several organs from wild-type (wt) and Toll-like receptor-2–deficient
(TLR2/) mice detected by a highly sensitive CCD (charge-coupled device) camera (IVIS imaging system; Xenogen) 12 and 24 h after intracerebral
injection of cfu of S. pneumoniae. Results from 1 wt and 1 TLR2/ mouse are shown. Kd, kidney; Lg, lung; Lv, liver; Sp, spleen; Th,33 10
thymus.
to cure the sepsis. It is known that wt mice treated in the first
24 h after infection with ceftriaxone (80 mg/kg every 12 h for
5 days) survive without apparent signs of meningitis [25]. Delay
of treatment beyond 30 h leads to death in 150% of the infected
mice [25]. We treated infected mice with ceftriaxone after S.
pneumoniae infection, and the obtained clinical scores and sur-
vival rates of both ceftriaxone-treated and control mice are
shown in table 2. With ceftriaxone treatment, all wt mice sur-
vived without any clinical signs of disease after 6 days, whereas
4 (27%) of 15 TLR2/ mice died despite treatment ( ,P ! .04
Kaplan-Meier analysis). As described above, all untreated wt
and TLR2/ mice died within 4–6 days (data not shown).
Treatment failure in TLR2/ mice could be explained by the
fact that at the initiation of the treatment (18 h after infection),
7% of TLR2/ mice but none of the wt mice were severely
sick. By day 6, 27% of the treated TLR2/ mice remained
severely ill and subsequently died, whereas all wt mice recovered
during treatment.
TLR2/ mice have a higher bacterial load in brain and stronger
meningeal inflammation after intracerebral infection with S. pneu-
moniae than do wt mice. To further explain the high suscep-
tibility of TLR2/ mice to S. pneumoniae meningitis, we ex-
amined bacterial counts, leukocyte recruitment, and TNF release
in the CSF as well as bacterial densities in the brain. Monitoring
of meningitis in animals intracerebrally injected with luciferase-
tagged S. pneumoniae revealed a higher fluorescence intensity in
TLR2/ brains than in wt brains between 2 and 24 h after
infection (figure 4A). Twenty-four hours after infection, mice were
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Table 2. Effect of ceftriaxone treatment on
survival during Streptococcus pneumoniae men-
ingitis in wild-type (wt) and Toll-like receptor-
2–deficient (TLR2/) mice.
Mouse strain,
days after infection
No. (%) of
mice showing
severe lethargy Survivors, %
wt (n p 15)
1 0 100
2 1 (7) 100
3 1 (7) 100
4 1 (7) 100
6 0 100
TLR2/ (n p 15)
1 1 (7) 100
2 3 (20) 100
3 3 (20) 100
4 4 (27) 87
6 4 (27) 73
NOTE. Ceftriaxone treatment (80 mg/kg) was ad-
ministered intraperitoneally every 12 h for 5 days, start-
ing 18 h after intracerebral injection of cfu of33 10
S. pneumoniae. , TLR2/ vs. wt mice (log-rankP ! .04
test in Kaplan-Meier analysis).
killed, and the photon emission was stronger and more widely
spread in isolated brains of TLR2/ mice than in those of wt
mice (figure 4A). In particular, signals from bacteria were dif-
ferently distributed in TLR2/ and wt mice. In contrast to the
picture in wt mice, bacteria were not accumulated in the ventricles
of TLR2/ mice but concentrated on the ipsilateral and con-
tralateral sides of the injection site. Furthermore, a quantitative
time course analysis of emitted fluorescence from infectedanimals
showed a more rapid bacterial growth in TLR2/ mice, com-
pared with wt mice, which was most pronounced already 2 h
after S. pneumoniae inoculation (figure 4B). Counting of colony-
forming units in ipsilateral and contralateral brain hemispheres
24 h after infection of the left side of the brain confirmed that,
in both parts, bacterial numbers were higher in TLR2/ than
wt mice (median, cfu [left] and cfu [right] in7 71.8 10 1.2 10
TLR2/ mice, and cfu [left] and cfu [right]5 57.4 10 8.8 10
in wt mice; ). Counting of colony-forming units in brainP ! .04
homogenates 24 h after intracisternal infection with S. pneu-
moniae confirmed that bacterial numbers were also significantly
higher in TLR2/ than wt mice when the intracisternal route of
infection was used (median, cfu and cfu in5 46.2 10 6.8 10
TLR2/ and wt mice, respectively; , Mann-Whitney UP ! .04
test).
Twelve hours after intracerebral infection, TLR2/ mice
showed a lower influx of leukocytes, compared with wt mice
( , and leukocytes/mL ofmean SD 1703 186 12,110 3691
CSF, respectively; ; figure 5A). After this time point,P ! .05
leukocyte numbers and bacterial counts in the CSF of the 2
groups were almost identical (figure 5B). As expected, infil-
trating polymorphonuclear cell numbers and bacterial counts
in the CSF were similar in TLR2/ and wt mice after intra-
cisternal infection, as we had observed in the intracerebral in-
fection model.
Meningeal inflammation, as assessed by TNF activity in the
CSF, was significantly higher in TLR2/ than in wt mice 24
h after infection with S. pneumoniae ( and1077 201 705
4 pg/mL of CSF, respectively; ; figure 5C). Early after7 P ! .02
infection, at 6 and 12 h, TNF activity was low or below de-
tection (!20 pg/mL), and, after 48 h, the difference between
TLR2/ mice and wt mice was no longer statistically signifi-
cant, because of high variability (figure 5C).
An association between disease severity and meningeal in-
flammation was documented by a significant relationship be-
tween TNF activity in the CSF and severity score 24 h after
infection ( ; ; data not shown). Thus, the levelrp 0.589 P ! .001
of TNF in CSF might reflect the intensity of clinical signs during
the first day of infection.
To investigate whether infiltrating leukocytes contribute to
meningeal inflammation during S. pneumoniae meningitis, we
analyzed TNF activity in the CSF in infected mice rendered
leukopenic by cyclophosphamide. As shown in figure 6, TNF
activity was significantly decreased in leukopenic TLR2/ mice,
compared with immunocompetent mice 24 h after infection
( ). In contrast, no difference in TNF activity was observedP ! .05
in wt mice with or without cyclophosphamide pretreatment.
TLR2/ mice have enhanced BBB permeability after intra-
cerebral infection with S. pneumoniae. Alteration of the BBB
is a consequence of meningeal inflammation. Therefore, we
analyzed changes in BBB permeability during S. pneumoniae
meningitis with the Evans blue extravasation method.
Measures of BBB permeability and severity of the disease in
wt and TLR2/ mice are presented in table 3. Infection with
S. pneumoniae induced alteration of the BBB in both wt and
TLR2/ mice, as evidenced by higher Evans blue concentra-
tions in brains of TLR2/ mice, compared with control mice.
This BBB disruption occurred early in disease (24 h) and was
stronger in TLR2/ mice than in wt mice. At the same time,
TLR2/ mice showed more severe symptoms of meningitis
than did wt mice (table 3). In addition, meningeal inflammation,
assessed by TNF in the CSF, was significantly related to BBB
permeability ( 8; ; data not shown).rp 0.76 P ! .02
Discussion
We have studied the in vivo role of TLR2 in an adult mouse
model of S. pneumoniae meningitis. TLR2/ mice had more
severe clinical symptoms than did wt mice and subsequently
showed earlier death. Similar results were obtained with L.
monocytogenes as the infecting agent (table 1). This result is in
agreement with a previous report on increased mortality of
TLR2/ mice from S. aureus sepsis [26]. In that model,
TLR2/ mice showed reduced systemic bacterial clearance,
compared with wt mice, after a high but not after a low intra-
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Figure 4. A, Time course of infection in wild-type (wt) and Toll-like receptor-2–deficient (TLR2/) mice after intracerebral injection of
cfu of luciferase-tagged Streptococcus pneumoniae. Images from 1 animal in each group at time of infection (0 h) and 2, 4, 6, 12, and 2433 10
h after infection and isolated brains 24 h after infection are shown. B, Emitted light was also quantified by LivingImage software (Xenogen) and
shown as bacterial growth gradient (calculated as ratio between emitted photons and time elapsed after infection). Results from individual mice
are shown, with median (horizontal line). ** , repeated-measures analysis of variance (ANOVA) ( and at 2 and 4 h,P ! .0001 np 11 np 10
and at 6 and 12 h, and and at 24 h, for wt and TLR2/ mice, respectively).np 10 np 9 np 6 np 5
venous inoculum. According to the authors, this was due to
failure to recognize invading bacteria [26]. Instead, in our model
with a low inoculum in the brain, systemic host defense was
not impaired in the absence of TLR2, because similar plasma
levels of IL-6 and numbers of bacteria were observed in blood
and organs of TLR2/ and wt mice. Moreover, in ceftriaxone-
injected animals, in which the infection is successfully treated,
27% of the TLR2/ mice died, whereas all wt mice survived.
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Figure 5. Time course of cerebrospinal fluid (CSF) parameters in
wild-type (wt) and Toll-like receptor-2–deficient (TLR2/) mice
( at each time point in both groups) after intracerebral injectionnp 12
of cfu of Streptococcus pneumoniae. Pooled CSF from 4 mice33 10
was collected at indicated times after infection. Infiltrating leukocytes
(A), bacterial numbers (B), and tumor necrosis factor (TNF) levels
(C) were analyzed in CSF. Results of 3 independent experiments are
shown as . When errors bars are not seen, they fall withinmean SD
symbol. * and ** , both by the Wilcoxon signed rank test.P ! .05 P ! .02
Figure 6. Tumor necrosis factor (TNF) levels in cerebrospinal fluid
(CSF) in leukocyte-depleted and immunocompetent control mice after
intracerebral injection of cfu of Streptococcus pneumoniae. In33 10
each experiment, pooled CSF from 4 mice was collected 24 h after
infection. Results of 3 independent experiments are shown as mean 
SD. ** , nonparametric Wilcoxon signed rank test. LeukocyteP ! .05
depletion in CSF was in Toll-like receptor-2–deficient81.2% 20.1%
(TLR2/) mice and in wild-type (wt) mice.76.2% 10.5%
This indicates that the higher mortality in TLR2/ mice was
not due to defective bacterial clearance in the periphery.
We observed more bacteria in the brains, but not in the CSF,
of TLR2/ mice. More rapid growth, which was detectable as
early as 2 h after infection, was associated with a protracted
accumulation of the bacteria around the site of injection in
TLR2/ mice. This was in contrast to wt mice, in which the
bacteria were mainly in the ventricles after 24 h. It is known
that TLR2 is constitutively expressed in the choroid plexus and
the lateral ventricle lining [27]. It can be hypothesized that the
lack of TLR2 in the choroidal epithelia and/or endothelia and
in the ependymal cells contributed to the particular distribution
pattern of the bacteria by altering the CSF flow. The different
localization of the bacteria in brains of wt and TLR2/ mice
probably also explains why the numbers of colony-forming
units in CSF were similar in both strains.
Leukocyte infiltration following bacterial invasion into the
central nervous system is correlated with brain edema and in-
jury in bacterial meningitis [28, 29]. The rapid increased bac-
terial growth in brain homogenates of TLR2/ mice may, in
turn, have contributed to the enhanced inflammation and to
the earlier aggravation of the symptoms in these animals. De-
spite higher bacterial numbers in brain, pleocytosis was not
significantly different in wt and TLR2/ mice, except for a
transient delay in leukocyte recruitment 12 h after infection in
TLR2/ mice. Perhaps the delayed leukocyte influx into the
CSF could be explained by a lack of TLR2 action on integrin
or intercellular adhesion molecule (ICAM) expression, because
it has been shown that blocking of the integrin CD18 and of
the adhesion molecule ICAM attenuated meningeal inflam-
mation and tissue damage [30, 31]. However, it is also possible
that the recruitment of leukocytes may have been delayed in
TLR2/ mice because of the lack of TLR2 activity on IL-8
[32]. Indeed, a previous study showed that intravenous treat-
ment with antibody against IL-8 attenuates the neutrophil pleo-
cytosis during experimental pneumococcal meningitis [33].
Despite the slower early influx of leukocytes, we observed
higher TNF activity during S. pneumoniae meningitis in CSF of
TLR2/ than of wt mice. TNF is elevated in CSF in human
and experimental meningitis. It has detrimental effects, because
its neutralization decreases meningeal inflammation, as shown
in a rabbit pneumococcal meningitis model [34, 35]. However,
the total lack of TNF also adversely effects host defense in men-
ingitis. Indeed, mice with a targeted deletion of TNF die earlier
JID 2002;186 (15 September) TLR2 in Pneumococcal Meningitis 805
Table 3. Blood-brain barrier permeability and clinical score in Toll-
like receptor-2–deficient (TLR2/) and wild-type (wt) mice after in-
tracerebral injection of cfu of Streptococcus pneumoniae.33 10
Mouse
strain
24 h 48 h
Clinical
scorea
Evans
blue stainb
Clinical
scorea
Evans
blue stainb
wt 1.3 (1–2.8) 1.1  0.1 3.5 (3–4) 3.4  1.9
TLR2/ 1.9 (1–3) 1.3  0.6 4.9 (4.8–5) 7.0  0.9
a Data are median (range) clinical score. See Materials and Methods for a
description of the scoring system.
b Data are fold increase, compared with uninfected control mice.meanSD
than control mice from intracerebral S. pneumoniae infection be-
cause of the lack of systemic clearance of bacteria [36]. A systemic
protective effect of TNF in our model is unlikely, in view of
similar signs of sepsis in TLR2/ and wt mice. An important
finding of the present study is that, paradoxically, TLR2/ mice
show an increased inflammation after infection. Thus, it appears
that these animals are characterized by inefficient regulation of
the inflammatory reaction. Because TLR2/ mice had more
TNF activity in the CSF than did wt mice, it is tempting to
speculate that the engagement of TLR2 contributes to a down-
regulation of the TNF in the CSF. This is not ascribed to an
increased production of IL-10 (data not shown) and might be
associated with an altered release of TNF from intracellularstores
and the cell surface.
The consequence of meningeal inflammation is an alteration
of the BBB integrity. In the present study, the BBB disruption
was markedly increased in TLR2/ mice, compared with con-
trol mice, and was related to TNF levels in the CSF. This
corroborates the known role of TNF in BBB disruption and
consequently in the course of disease [35, 37, 38].
Our observation of a stronger in vivo TNF induction in
TLR2/ than in wt mice is in contrast to the reduced in vitro
TNF production of TLR2/ in macrophages in response to S.
aureus [26]. However, an important difference in our experi-
mental model is the use of live bacteria, whereas that study [26]
was conducted with heat-killed bacteria. We therefore conclude
that live S. pneumoniae and their turnover products induce TNF
differently than do heat-killed bacteria. It is likely that, during
infection, other receptors are activated together with TLR2.
The nature of these other receptors is not clear. They could be
other TLRs, such as TLR1 and TLR6, which are also triggered
by bacterial products [39]. In this case, their stimulation led to
the release of large amounts of TNF, which are higher that
those induced in the presence of TLR2. This might occur be-
cause these TLRs show sequence similarities in their intracy-
toplasmic regions and then share common transducing mech-
anisms. Other receptors involved in this signaling could be
specific for S. pneumoniae products, such as platelet-activating
factor receptors [7] or C-reactive protein [40]. Finally, another
possibility is that triggering of TLR2 on a particular cell type
only might lead to the regulation of TNF. However, in this
case, it is not clear how the engagement of TLR2 would down-
regulate the TNF release.
The same accelerated death rate as for those infected with
S. pneumoniae was also observed in Listeria-infected TLR2/
mice, yet they and Listeria-infected wt mice had similar TNF
activity in the CSF (data not shown). This suggests that dif-
ferent mechanisms are involved in S. pneumoniae and L. mono-
cytogenes meningitis.
As reported elsewhere, in L. monocytogenes meningitis,
monocytes contributed to the leukocyte infiltration in CSF,
whereas S. pneumoniae meningitis caused only polymorpho-
nuclear leukocyte accumulation [41]. Together with our recent
observation that TLR2 protein is constitutively expressed in
mouse polymorphonuclear leukocytes, but not in macrophages
(authors’ unpublished data), the excess TNF in S. pneumoniae
meningitis may be polymorphonuclear leukocyte–derived. To
confirm this hypothesis, we investigated which cells contributed
to the TNF release in the subarachnoid space during S. pneu-
moniae meningitis. Depletion of leukocytes by cyclophospha-
mide treatment before infection led to a decrease in TNF level
in TLR2/ but not in wt mice. This result validated that leu-
kocytes participated in TNF production but were not the only
source of TNF in TLR2/ mice. Brain microvascular endo-
thelia have been shown to produce TNF in pneumococcal men-
ingitis or after stimulation with cell walls of S. pneumoniae [7,
42]. Furthermore, we and others could show that primary cul-
tures of astrocytes, microglial cells, and neurons release TNF
after stimulation with live S. pneumoniae (authors’ unpublished
data) and pneumococcal cell wall components [43].
In conclusion, the mouse S. pneumoniae meningitis model de-
scribed here is fatal for both wt and TLR2/ mice. The clinical
course of meningitis, the number of bacteria, the level of menin-
geal inflammation, and BBB damage are aggravated in mice
lacking TLR2. Taken together, these results indicate, for the first
time, a contribution of TLR2 in regulation of bacterial clearing
and inflammatory response in pneumococcal meningitis.
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